Inozyme Pharma, Inc. Annual Weighted Average Number of Shares Outstanding, Basic from 2021 to 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Inozyme Pharma, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2021 to 2023.
  • Inozyme Pharma, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 61.9M shares, a 38.1% increase year-over-year.
  • Inozyme Pharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 51.8M shares, a 37.3% increase from 2022.
  • Inozyme Pharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 37.8M shares, a 60.3% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 51.8M +14.1M +37.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-12
2022 37.8M +14.2M +60.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-12
2021 23.6M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.